Nonlinear dynamics of CAR-T cell therapy

被引:0
|
作者
Fassoni, Artur C. [1 ,2 ]
Braga, Denis C. [1 ]
机构
[1] Univ Fed Itajuba, Inst Matemat & Computacao, BR-37500903 Itajuba, Brazil
[2] Tech Univ Dresden, Inst Med Informat & Biometry, Dresden, Germany
关键词
Nonlinear phenomena; Differential equations; Hopf bifurcation; Bogdanov-Takens bifurcation; Mathematical oncology; Immunotherapy; MODELS; PROLIFERATION; BIFURCATIONS; OSCILLATIONS;
D O I
10.1016/j.chaos.2024.115871
中图分类号
O1 [数学];
学科分类号
0701 ; 070101 ;
摘要
Chimeric antigen receptor T-cell (CAR-T) therapy is considered a promising cancer treatment. The dynamic response to this therapy can be broadly divided into a short-term phase, ranging from weeks to months, and a long-term phase, ranging from months to years. While the short-term response, encompassing the multiphasic kinetics of CAR-T cells, is better understood, the mechanisms underlying the outcomes of the long-term response, characterized by sustained remission, relapse, or disease progression, remain less understood due to limited clinical data. Here, we analyze the long-term dynamics of a previously validated mathematical model of CAR-T cell therapy. We perform a comprehensive stability and bifurcation analysis, examining model equilibria and their dynamics over the entire parameter space. Our results show that therapy failure results from a combination of insufficient CAR-T cell proliferation and increased tumor immunosuppression. By combining different techniques of nonlinear dynamics, we identify Hopf and Bogdanov-Takens bifurcations, which allow to elucidate the mechanisms behind oscillatory remissions and transitions to tumor escape. In particular, rapid expansion of CAR-T cells leads to oscillatory tumor control, while increased tumor immunosuppression destabilizes these oscillations, resulting in transient remissions followed by relapse. Our study highlights different mathematical tools to study nonlinear models and provides critical insights into the nonlinear dynamics of CAR-T therapy arising from the complex interplay between CAR-T cells and tumor cells.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] CAR-T Cell Therapy
    Ahmad, Aamir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12)
  • [2] CAR-T cell therapy
    San Segundo, Lucrecia Yanez
    MEDICINA CLINICA, 2021, 156 (03): : 123 - 125
  • [3] CAR-T cell therapy for T cell malignances
    Watanabe, Keisuke
    CANCER SCIENCE, 2025, 116 : 1784 - 1784
  • [4] CAR-T cell therapy for T cell malignances
    Watanabe, Keisuke
    CANCER SCIENCE, 2024, 115 : 812 - 812
  • [5] Biomarkers for CAR-T Cell Therapy
    不详
    TRANSFUSIONSMEDIZIN, 2024, 14 (03) : 123 - 124
  • [6] CAR-T Cell Therapy and Beyond
    Dotti, Gianpietro
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S4 - S4
  • [7] CAR-T Cell Therapy for Lymphoma
    Ramos, Carlos A.
    Heslop, Helen E.
    Brenner, Malcolm K.
    ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 165 - 183
  • [8] CAR-T Cell Therapy and the Neurointensivist
    Wijdicks, Eelco F. M.
    Rabinstein, Alejandro A.
    Lin, Yi
    NEUROCRITICAL CARE, 2024, : 691 - 694
  • [9] CAR-T Cell Therapy for T-Cell Malignancies
    Testa, Ugo
    Chiusolo, Patrizia
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [10] Teaming up for CAR-T cell therapy
    Waesch, Ralph
    Munder, Markus
    Marks, Reinhard
    HAEMATOLOGICA, 2019, 104 (12) : 2335 - 2336